TapewireFind a company

person · Reporting owner

OLDAKER WILLIAM CLYDE

Disclosed activity across 2 companies

Tapewire entity
156160
SEC CIK
0001397571

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
PALISADE BIO, INC.CUR · Entity 5803DirectorJuly 01, 2019July 03, 2019

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

PALISADE BIO, INC.

Report date July 01, 2019 · Filed July 03, 2019

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock Purchase OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.30 · Expires 2029-07-01Direct187,510 Reported balance After 2019-07-01 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2019-07-01 · Grant · Acquired 187,510 · Balance 187,510

F1: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

Filing footnotes · ownership attribution and instrument terms

F1: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

WashingtonFirst Bankshares, Inc.

Report date January 01, 2018 · Filed January 03, 2018

Section 16 reporting ended · disclosed 2018-01-03. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2018-01-01 transaction · row 1
1 source row

Row 1 · 2018-01-01 · Disposition to issuer · Disposed 153,907 · Balance 0

F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of May 15, 2017, by and among Sandy Spring Bancorp, Inc. ("Sandy Spring"), WashingtonFirst Bankshares, Inc. ("WashingtonFirst") and Touchdown Acquisition, Inc., a wholly-owned subsidiary of Sandy Spring ("Merger Sub"). Merger Sub merged (the "First-Step Merger") with and into WashingtonFirst, with WashingtonFirst continuing as the surviving entity and immediately thereafter, WashingtonFirst merged with and into Sandy Spring, with Sandy Spring continuing as the surviving entity. At the effective time of the First-Step Merger (the "Effective Time"), each share of WashingtonFirst common stock issued and outstanding immediately prior to such time was converted into the right to receive 0.8713 shares of Sandy Spring common stock.

Common StockSEC Table I · non-derivativeIndirectBy Spouse IRA0 Reported balance After 2018-01-01 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 2 · 2018-01-01 · Disposition to issuer · Disposed 28,163 · Balance 0

F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of May 15, 2017, by and among Sandy Spring Bancorp, Inc. ("Sandy Spring"), WashingtonFirst Bankshares, Inc. ("WashingtonFirst") and Touchdown Acquisition, Inc., a wholly-owned subsidiary of Sandy Spring ("Merger Sub"). Merger Sub merged (the "First-Step Merger") with and into WashingtonFirst, with WashingtonFirst continuing as the surviving entity and immediately thereafter, WashingtonFirst merged with and into Sandy Spring, with Sandy Spring continuing as the surviving entity. At the effective time of the First-Step Merger (the "Effective Time"), each share of WashingtonFirst common stock issued and outstanding immediately prior to such time was converted into the right to receive 0.8713 shares of Sandy Spring common stock.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of May 15, 2017, by and among Sandy Spring Bancorp, Inc. ("Sandy Spring"), WashingtonFirst Bankshares, Inc. ("WashingtonFirst") and Touchdown Acquisition, Inc., a wholly-owned subsidiary of Sandy Spring ("Merger Sub"). Merger Sub merged (the "First-Step Merger") with and into WashingtonFirst, with WashingtonFirst continuing as the surviving entity and immediately thereafter, WashingtonFirst merged with and into Sandy Spring, with Sandy Spring continuing as the surviving entity. At the effective time of the First-Step Merger (the "Effective Time"), each share of WashingtonFirst common stock issued and outstanding immediately prior to such time was converted into the right to receive 0.8713 shares of Sandy Spring common stock.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
July 01, 2019 Filed Jul 3, 2019 21:35 UTC PALISADE BIO, INC. CUR · Entity 5803 GrantCommon Stock Purchase Option · Derivative 187,510 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0001171843-19-004418 · ownership.xml · derivative · entry 1

OLDAKER WILLIAM CLYDE · CIK 0001397571 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 187,510

Underlying: Common Stock · 187,510 shares

Expires 2029-07-01

F1 · security: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

Read SEC document
July 02, 2018 Filed Jul 5, 2018 20:31 UTC PALISADE BIO, INC. CUR · Entity 5803 GrantCommon Stock Purchase Option · Derivative 59,660 $0.00 Strike: $1.11 $0.00
Disclosure

SEC source: 0001171843-18-005064 · formfour.xml · derivative · entry 1

OLDAKER WILLIAM CLYDE · CIK 0001397571 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,660

Underlying: Common Stock · 59,660 shares

Expires 2028-07-02

F1 · security: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19.

F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19.

Read SEC document
January 01, 2018 Filed Jan 3, 2018 11:36 UTC WashingtonFirst Bankshares, Inc. WFBI · Entity 170571 Disposition to issuerCommon Stock 28,163 $0.00 $0.00
Disclosure

SEC source: 0001225208-18-000181 · doc4.xml · nonDerivative · entry 2

OLDAKER WILLIAM CLYDE · CIK 0001397571 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse IRA

Disclosed balance after: 0

F1 · price: Disposed of pursuant to the Agreement and Plan of Merger, dated as of May 15, 2017, by and among Sandy Spring Bancorp, Inc. ("Sandy Spring"), WashingtonFirst Bankshares, Inc. ("WashingtonFirst") and Touchdown Acquisition, Inc., a wholly-owned subsidiary of Sandy Spring ("Merger Sub"). Merger Sub merged (the "First-Step Merger") with and into WashingtonFirst, with WashingtonFirst continuing as the surviving entity and immediately thereafter, WashingtonFirst merged with and into Sandy Spring, with Sandy Spring continuing as the surviving entity. At the effective time of the First-Step Merger (the "Effective Time"), each share of WashingtonFirst common stock issued and outstanding immediately prior to such time was converted into the right to receive 0.8713 shares of Sandy Spring common stock.

Read SEC document
January 01, 2018 Filed Jan 3, 2018 11:36 UTC WashingtonFirst Bankshares, Inc. WFBI · Entity 170571 Disposition to issuerCommon Stock 153,907 $0.00 $0.00
Disclosure

SEC source: 0001225208-18-000181 · doc4.xml · nonDerivative · entry 1

OLDAKER WILLIAM CLYDE · CIK 0001397571 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: Disposed of pursuant to the Agreement and Plan of Merger, dated as of May 15, 2017, by and among Sandy Spring Bancorp, Inc. ("Sandy Spring"), WashingtonFirst Bankshares, Inc. ("WashingtonFirst") and Touchdown Acquisition, Inc., a wholly-owned subsidiary of Sandy Spring ("Merger Sub"). Merger Sub merged (the "First-Step Merger") with and into WashingtonFirst, with WashingtonFirst continuing as the surviving entity and immediately thereafter, WashingtonFirst merged with and into Sandy Spring, with Sandy Spring continuing as the surviving entity. At the effective time of the First-Step Merger (the "Effective Time"), each share of WashingtonFirst common stock issued and outstanding immediately prior to such time was converted into the right to receive 0.8713 shares of Sandy Spring common stock.

Read SEC document
July 14, 2017 Filed Jul 18, 2017 20:31 UTC PALISADE BIO, INC. CUR · Entity 5803 GrantCommon Stock 18,622 $0.00 $0.00
Disclosure

SEC source: 0001171843-17-004169 · formfour.xml · nonDerivative · entry 1

OLDAKER WILLIAM CLYDE · CIK 0001397571 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,763

F1 · security: The shares represented are restricted stock grants pursuant to compensatory Annual Grant for director services of $100,000. The shares vest quarterly on 9/30/17, 12/31/17, 3/31/18, and 6/30/2018.

Read SEC document
May 05, 2017 Filed May 8, 2017 11:44 UTC WashingtonFirst Bankshares, Inc. WFBI · Entity 170571 Exercise / conversionStock Option · Derivative 1,215 $0.00 Strike: $10.29 $0.00
Disclosure

SEC source: 0001397571-17-000004 · wf-form4_149425823750688.xml · derivative · entry 5

OLDAKER WILLIAM CLYDE · CIK 0001397571 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,215 shares

Expires 2018-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 05, 2017 Filed May 8, 2017 11:44 UTC WashingtonFirst Bankshares, Inc. WFBI · Entity 170571 Exercise / conversionStock Option · Derivative 1,215 $0.00 Strike: $8.27 $0.00
Disclosure

SEC source: 0001397571-17-000004 · wf-form4_149425823750688.xml · derivative · entry 4

OLDAKER WILLIAM CLYDE · CIK 0001397571 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,215 shares

Expires 2019-12-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 05, 2017 Filed May 8, 2017 11:44 UTC WashingtonFirst Bankshares, Inc. WFBI · Entity 170571 Exercise / conversionCommon Stock 1,215 $10.29 $12,500.41
Disclosure

SEC source: 0001397571-17-000004 · wf-form4_149425823750688.xml · nonDerivative · entry 2

OLDAKER WILLIAM CLYDE · CIK 0001397571 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,907

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 05, 2017 Filed May 8, 2017 11:44 UTC WashingtonFirst Bankshares, Inc. WFBI · Entity 170571 Exercise / conversionCommon Stock 1,215 $8.27 $10,050.36
Disclosure

SEC source: 0001397571-17-000004 · wf-form4_149425823750688.xml · nonDerivative · entry 1

OLDAKER WILLIAM CLYDE · CIK 0001397571 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,692

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2017 Filed May 5, 2017 10:17 UTC WashingtonFirst Bankshares, Inc. WFBI · Entity 170571 Exercise / conversionStock Option · Derivative 3,487 $0.00 Strike: $13.17 $0.00
Disclosure

SEC source: 0001397571-17-000002 · wf-form4_149399385954735.xml · derivative · entry 3

OLDAKER WILLIAM CLYDE · CIK 0001397571 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,487 shares

Expires 2017-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Exercise price adjusted to account for the 5% stock dividend distributed on December 28, 2016.

F3 · derivative.underlying_shares: Number of shares adjusted to account for the 5% stock dividend distributed December 28, 2016.

Read SEC document
May 04, 2017 Filed May 5, 2017 10:17 UTC WashingtonFirst Bankshares, Inc. WFBI · Entity 170571 Exercise / conversionCommon Stock 3,487 $13.17 $45,917.51
Disclosure

SEC source: 0001397571-17-000002 · wf-form4_149399385954735.xml · nonDerivative · entry 1

OLDAKER WILLIAM CLYDE · CIK 0001397571 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,477

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes stock dividend of five percent that was distributed on December 28, 2016.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.